Alerce Investment Management, L.P.
In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 13, 2024), Alerce Investment Management, L.P. reported 5 stock positions worth $62.3 million. Its top holding was Annexon (ANNX) at 70.4% of the portfolio, followed by Akebia Therapeutics (AKBA, 12.2%) and Verona Pharma (VRNA, 9.5%). Compared with Q2 2024, it reduced 2. The biggest sale was Whitehawk Therapeutics (WHWK, shares −100%).
- Most Recent 13F
- Q4 2024
- Location
- Chicago, IL
- CIK
- 0001844002
- Portfolio Value
- $62.3M (Q3 2024)
- SEC Filing
- 0000895345-24-000559 ↗ filed Nov 13, 2024
Holdings Value
Holdings 5 stocks · $62.3M
| ANNX Annexon Inc. | 70.35% | 7,406,024 | $43.8M | No change |
| AKBA Akebia Therapeutics Inc. | 12.17% | 5,747,906 | $7.6M | No change |
| VRNA Verona Pharma Ltd. | 9.50% | 205,880 | $5.9M | Reduce -3.3% |
| AMWL American Well Corp. Class A | 7.97% | 523,785 | $5.0M | No change |
| WHWK Whitehawk Therapeutics Inc. filed as AADI BIOSCIENCE INC | 0.00% | 659 | $1K | Reduce -100.0% |
Portfolio Sells Q2 2024 → Q3 2024
Portfolio Buys Q2 2024 → Q3 2024
| None this quarter. | |||